Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)

1. Rodriguez-Vida, A.
2. Bamias, A.
3. Esteban, E.
4. Saez, M.I.
5. Lopez-Brea, M.
6. Castellano, D.
7. Caballero, C.
8. Gonzalez-Larriba, J.L.
9. Calvo, E.
10. Macia, S.
11. Ravaud, A.
12. Bellmunt, J.